|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; [BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine; Imatinib Mesylate inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; nilotinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] |
CTD |
PMID:16849647 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
|
|
G |
ADCYAP1 |
adenylate cyclase activating polypeptide 1 |
increases secretion multiple interactions |
ISO |
ADCYAP1 protein results in increased secretion of Histamine Dinoprostone inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; Galanin inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; IL1B protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; Misoprostol inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; SST protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; TNF protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] |
CTD |
PMID:11164953 |
|
NCBI chr18:904,411...912,172
Ensembl chr18:904,871...912,172
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
multiple interactions decreases response to substance increases activity |
EXP ISO |
Histamine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] Alprenolol inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine]; carvedilol inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine]; ICI 118551 inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine] [Epinephrine results in increased activity of ADRB2 protein] which results in increased secretion of Histamine; [Isoproterenol results in increased activity of ADRB2 protein] which results in increased secretion of Histamine; [Terbutaline results in increased activity of ADRB2 protein] which results in increased secretion of Histamine Histamine results in increased activity of ADRB2 protein |
CTD |
PMID:11164953 PMID:12198331 PMID:17196553 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
ALOX5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP |
ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]; zileuton inhibits the reaction [ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]] |
CTD |
PMID:9609743 |
|
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
|
|
G |
ALOX5AP |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
EXP |
ALOX5AP protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]; L 655238 inhibits the reaction [ALOX5AP protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]]; MK-886 inhibits the reaction [ALOX5AP protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]] |
CTD |
PMID:9609743 |
|
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
|
|
G |
AMBP |
alpha-1-microglobulin/bikunin precursor |
decreases secretion |
ISO |
AMBP protein results in decreased secretion of Histamine |
CTD |
PMID:9579392 |
|
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
increases metabolic processing |
EXP |
AOC1 protein results in increased metabolism of Histamine |
CTD |
PMID:12072962 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
AQP5 |
aquaporin 5 |
affects localization multiple interactions decreases expression |
EXP |
Histamine affects the localization of AQP5 protein Glycyrrhizic Acid inhibits the reaction [Histamine results in decreased expression of AQP5 protein]; prolinedithiocarbamate inhibits the reaction [Histamine results in decreased expression of AQP5 protein] |
CTD |
PMID:19443731 PMID:29452068 |
|
NCBI chr12:49,961,872...49,965,682
Ensembl chr12:49,961,872...49,965,682
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Histamine results in increased expression of BAX mRNA |
CTD |
PMID:36565801 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
ISO |
Histamine results in decreased expression of BCL2 mRNA |
CTD |
PMID:36565801 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCR |
BCR activator of RhoGEF and GTPase |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; [BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine; Imatinib Mesylate inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine]; nilotinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] |
CTD |
PMID:16849647 |
|
NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037
|
|
G |
CALCA |
calcitonin related polypeptide alpha |
multiple interactions increases secretion |
ISO |
[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein; Dinoprostone inhibits the reaction [Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]]; Flurbiprofen inhibits the reaction [Histamine results in increased secretion of CALCA protein]; Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein] |
CTD |
PMID:11166334 PMID:12791437 PMID:14991081 |
|
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
|
|
G |
CASP3 |
caspase 3 |
increases expression |
ISO |
Histamine results in increased expression of CASP3 mRNA; Histamine results in increased expression of CASP3 protein |
CTD |
PMID:36565801 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
affects expression decreases activity |
ISO |
Histamine affects the expression of CAT protein Histamine results in decreased activity of CAT protein |
CTD |
PMID:17729160 PMID:36565801 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Lipopolysaccharides promotes the reaction [Histamine results in increased expression of CCL2 protein]; TNF protein promotes the reaction [Histamine results in increased expression of CCL2 protein] |
CTD |
PMID:11336536 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions |
EXP |
[HRH4 protein results in increased susceptibility to Histamine] which results in decreased expression of CCND1 protein |
CTD |
PMID:22363581 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CD14 |
CD14 molecule |
affects expression multiple interactions |
EXP |
Histamine affects the expression of CD14 protein HRH2 protein affects the reaction [Histamine affects the expression of CD14 protein] |
CTD |
PMID:14499251 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD40 |
CD40 molecule |
multiple interactions |
EXP |
[alpha-fluoromethylhistamine results in decreased chemical synthesis of Histamine] which results in decreased expression of CD40 protein; [tiotidine inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein]] which results in decreased expression of CD40 protein; [Triprolidine inhibits the reaction [Histamine binds to and results in increased activity of HRH1 protein]] which results in decreased expression of CD40 protein |
CTD |
PMID:11306145 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD80 |
CD80 molecule |
multiple interactions |
EXP |
Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein]]; Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein]] |
CTD |
PMID:12538815 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
multiple interactions |
EXP |
[HRH4 protein results in increased susceptibility to Histamine] which results in decreased expression of CDK2 protein |
CTD |
PMID:22363581 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1A protein |
CTD |
PMID:22363581 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein |
CTD |
PMID:22363581 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CHRM3 |
cholinergic receptor muscarinic 3 |
multiple interactions affects response to substance |
ISO |
CHRM3 protein affects the reaction [Histamine results in increased secretion of Acids] CHRM3 protein affects the susceptibility to Histamine |
CTD |
PMID:14724830 |
|
NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452
|
|
G |
CLCA1 |
chloride channel accessory 1 |
increases expression |
EXP |
Histamine results in increased expression of CLCA1 mRNA |
CTD |
PMID:17622767 |
|
NCBI chr 1:86,468,927...86,500,259
Ensembl chr 1:86,468,368...86,500,259
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions decreases phosphorylation |
EXP |
Glycyrrhizic Acid inhibits the reaction [Histamine results in decreased phosphorylation of CREB1 protein]; prolinedithiocarbamate inhibits the reaction [Histamine results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:29452068 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CSF1 |
colony stimulating factor 1 |
decreases expression |
ISO |
Histamine results in decreased expression of CSF1 mRNA |
CTD |
PMID:9657254 |
|
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
|
|
G |
CSF2 |
colony stimulating factor 2 |
increases expression increases secretion multiple interactions |
EXP ISO |
Histamine results in increased expression of CSF2 protein CSF2 results in increased secretion of Histamine Histamine results in increased secretion of CSF2 protein Particulate Matter analog promotes the reaction [Histamine results in increased secretion of CSF2 protein]; Vehicle Emissions analog promotes the reaction [Histamine results in increased secretion of CSF2 protein] |
CTD |
PMID:9606035 PMID:9685678 PMID:9856766 PMID:10051702 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions increases secretion increases expression |
EXP |
[Histamine co-treated with lipopolysaccharide, E. coli O26-B6] results in decreased expression of CXCL8 mRNA; Cyclosporine inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; Dexamethasone inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; Dexamethasone inhibits the reaction [Histamine results in increased expression of CXCL8 protein]; Diphenhydramine inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; Diphenhydramine inhibits the reaction [Histamine results in increased expression of CXCL8 protein]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased secretion of CXCL8 protein]; Histamine results in increased activity of [CXCL8 protein binds to RELA protein]; L 655238 inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; Leukotriene B4 inhibits the reaction [zileuton inhibits the reaction [Histamine results in increased expression of CXCL8 protein]]; Lipopolysaccharides promotes the reaction [Histamine results in increased expression of CXCL8 protein]; MK-886 inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; MK-886 inhibits the reaction [Histamine results in increased expression of CXCL8 protein]; Particulate Matter analog promotes the reaction [Histamine results in increased secretion of CXCL8 protein]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased secretion of CXCL8 protein]; TNF protein promotes the reaction [Histamine results in increased expression of CXCL8 protein]; Vehicle Emissions analog promotes the reaction [Histamine results in increased secretion of CXCL8 protein]; zileuton inhibits the reaction [Histamine results in increased expression of CXCL8 mRNA]; zileuton inhibits the reaction [Histamine results in increased expression of CXCL8 protein] Histamine results in increased expression of CXCL8 mRNA; Histamine results in increased expression of CXCL8 protein |
CTD |
PMID:9609743 PMID:10051702 PMID:11336536 PMID:29452068 PMID:29594315 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
EDN1 |
endothelin 1 |
multiple interactions |
EXP |
EDN1 protein results in decreased activity of [Atropine co-treated with Histamine] |
CTD |
PMID:12906840 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
EGFR protein affects the reaction [Histamine results in increased secretion of MMP1 protein] |
CTD |
PMID:17656145 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions increases expression increases activity |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased expression of F3]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Histamine results in increased expression of F3]; [Histamine co-treated with splitomicin] results in increased expression of F3 protein; Chlorpheniramine inhibits the reaction [Histamine results in increased expression of F3]; Diphenhydramine inhibits the reaction [Histamine results in increased expression of F3]; pyrazolanthrone inhibits the reaction [Histamine results in increased expression of F3]; Pyrilamine inhibits the reaction [Histamine results in increased activity of F3 protein]; Pyrilamine inhibits the reaction [Histamine results in increased expression of F3]; SB 203580 inhibits the reaction [Histamine results in increased expression of F3]; wortmannin promotes the reaction [Histamine results in increased expression of F3] Histamine results in increased expression of F3 mRNA; Histamine results in increased expression of F3 protein |
CTD |
PMID:16009787 PMID:20978007 PMID:25569083 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FCER1A |
Fc epsilon receptor Ia |
affects secretion |
EXP |
FCER1A polymorphism affects the secretion of Histamine |
CTD |
PMID:17125826 |
|
NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224
|
|
G |
FGF1 |
fibroblast growth factor 1 |
increases expression |
ISO |
Histamine results in increased expression of FGF1 protein |
CTD |
PMID:15264218 |
|
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA; Famotidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA] |
CTD |
PMID:9187264 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
GAST |
gastrin |
affects abundance increases secretion affects activity multiple interactions |
ISO |
GAST protein affects the abundance of Histamine GAST protein modified form results in increased secretion of Histamine; GAST protein results in increased secretion of Histamine Histamine affects the activity of GAST protein [fluanisone co-treated with Fentanyl co-treated with Midazolam] inhibits the reaction [GAST protein results in increased secretion of Histamine]; alpha-methylhistamine inhibits the reaction [GAST protein modified form results in increased secretion of Histamine]; Chloral Hydrate inhibits the reaction [GAST protein results in increased secretion of Histamine]; CXCL8 protein inhibits the reaction [GAST protein results in increased secretion of Histamine]; Dinoprostone inhibits the reaction [GAST protein results in increased secretion of Histamine]; Galanin inhibits the reaction [GAST protein results in increased secretion of Histamine]; Impromidine inhibits the reaction [GAST protein modified form results in increased secretion of Histamine]; Misoprostol inhibits the reaction [GAST protein results in increased secretion of Histamine]; Pentobarbital inhibits the reaction [GAST protein results in increased secretion of Histamine]; SST protein inhibits the reaction [GAST protein results in increased secretion of Histamine]; TNF protein inhibits the reaction [GAST protein results in increased secretion of Histamine]; Urethane inhibits the reaction [GAST protein results in increased secretion of Histamine] |
CTD |
PMID:2470453 PMID:10864877 PMID:11164953 PMID:12190085 PMID:12893847 PMID:14642791 PMID:16378173 More...
|
|
NCBI chr17:41,712,331...41,715,969
Ensembl chr17:41,712,331...41,715,969
|
|
G |
GHRL |
ghrelin and obestatin prepropeptide |
multiple interactions |
ISO |
Histamine affects the reaction [GHRL protein results in increased secretion of Acids] |
CTD |
PMID:16838121 |
|
NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947
|
|
G |
GUSB |
glucuronidase beta |
multiple interactions increases expression |
EXP |
fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein]; fexofenadine inhibits the reaction [Histamine results in increased expression of GUSB protein]; HRH1 protein promotes the reaction [Histamine results in increased expression of GUSB protein] |
CTD |
PMID:11238657 |
|
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
|
|
G |
HDC |
histidine decarboxylase |
increases chemical synthesis multiple interactions |
ISO EXP |
HDC protein results in increased chemical synthesis of Histamine [troglitazone results in decreased expression of HDC mRNA] which results in decreased secretion of Histamine |
CTD |
PMID:11834241 PMID:17075268 |
|
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
|
|
G |
HNMT |
histamine N-methyltransferase |
increases methylation multiple interactions |
EXP |
HNMT protein results in increased methylation of Histamine SK&F 91488 inhibits the reaction [HNMT protein results in increased methylation of Histamine] |
CTD |
PMID:7943261 |
|
NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
|
|
G |
HRH1 |
histamine receptor H1 |
increases activity affects binding multiple interactions increases expression affects response to substance |
EXP ISO |
Histamine results in increased activity of HRH1 protein HRH1 protein binds to Histamine 1-Methyl-3-isobutylxanthine inhibits the reaction [HRH1 protein promotes the reaction [Histamine results in decreased abundance of Cyclic AMP]]; [Histamine results in increased activity of HRH1 protein] which results in increased abundance of Calcium; [HRH1 protein binds to Histamine] which results in increased import of Calcium; [Triprolidine inhibits the reaction [Histamine binds to and results in increased activity of HRH1 protein]] which results in decreased expression of CD40 protein; [Triprolidine inhibits the reaction [Histamine binds to and results in increased activity of HRH1 protein]] which results in decreased expression of PTPRC protein; Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]; fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased abundance of Calcium]; fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein]; Guanosine Triphosphate analog affects the reaction [Histamine inhibits the reaction [Pyrilamine binds to HRH1 protein]]; Histamine inhibits the reaction [Pyrilamine binds to HRH1 protein]; Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]; HRH1 affects the reaction [Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]]; HRH1 protein affects the reaction [Histamine results in increased transport of fluorescein isothiocyanate bovine serum albumin]; HRH1 protein promotes the reaction [Histamine results in decreased abundance of Cyclic AMP]; HRH1 protein promotes the reaction [Histamine results in increased export of Calcium]; HRH1 protein promotes the reaction [Histamine results in increased expression of GUSB protein]; HRH1 protein promotes the reaction [Histamine results in increased expression of IL6 protein]; HRH1 protein promotes the reaction [Histamine results in increased metabolism of Phosphatidylinositols]; Quercetin inhibits the reaction [Histamine results in increased expression of HRH1 mRNA]; Triprolidine inhibits the reaction [[Histamine results in increased activity of HRH1 protein] which results in increased abundance of Calcium]; Triprolidine inhibits the reaction [Histamine binds to and results in increased activity of HRH1 protein]; Triprolidine inhibits the reaction [HRH1 protein promotes the reaction [Histamine results in decreased abundance of Cyclic AMP]]; Triprolidine inhibits the reaction [HRH1 protein promotes the reaction [Histamine results in increased export of Calcium]]; Triprolidine inhibits the reaction [HRH1 protein promotes the reaction [Histamine results in increased metabolism of Phosphatidylinositols]] HRH1 protein affects the susceptibility to Histamine [epinastine binds to and results in decreased activity of HRH1 protein] which affects the susceptibility to Histamine; [Histamine binds to and results in increased activity of HRH1 protein] which results in decreased susceptibility to Scopolamine; [Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein; [Histamine results in increased activity of HRH1 protein] which affects the transport of Potassium; [Tripelennamine binds to and results in decreased activity of HRH1 protein] which affects the susceptibility to Histamine; Histamine binds to and results in increased activity of HRH1 protein; Pyrilamine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in decreased susceptibility to Scopolamine]; Pyrilamine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein]; Ro 31-8220 inhibits the reaction [Histamine results in increased expression of HRH1 mRNA]; Triprolidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein] |
CTD |
PMID:2419744 PMID:11238657 PMID:11306145 PMID:11527950 PMID:12095164 PMID:12147327 PMID:12832840 PMID:15167971 PMID:16143415 PMID:16354729 PMID:18360087 PMID:19215234 PMID:20040740 PMID:23333628 PMID:32061592 More...
|
|
NCBI chr 3:11,137,238...11,263,557
Ensembl chr 3:11,137,093...11,263,557
|
|
G |
HRH2 |
histamine receptor H2 |
multiple interactions increases activity affects localization affects expression |
EXP ISO |
[Cimetidine binds to and results in decreased activity of HRH2 protein] results in decreased susceptibility to [Histamine co-treated with [Oxygen deficiency co-treated with Oxygen]]; [Histamine affects the localization of HRH2 protein] which affects the degradation of HRH2 protein; [Histamine binds to and results in increased activity of HRH2 protein] which results in decreased expression of IFNG mRNA; [Histamine binds to and results in increased activity of HRH2 protein] which results in increased abundance of Cyclic AMP; [Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA; [Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12A protein; [Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12B protein; [tiotidine inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein]] which results in decreased expression of CD40 protein; [tiotidine inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein]] which results in decreased expression of PTPRC protein; Burimamide inhibits the reaction [[Cyclic AMP binds to and results in increased activity of HRH2 protein] which results in increased abundance of Histamine]; Burimamide inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein]; Cimetidine inhibits the reaction [HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]]; Cyclic AMP promotes the reaction [[Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12A protein]; Cyclic AMP promotes the reaction [[Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12B protein]; Famotidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in increased expression of FOS mRNA]; Histamine binds to and results in increased activity of HRH2 protein; HRH2 protein affects the reaction [Histamine affects the expression of CD14 protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]]; HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]]; HRH2 protein promotes the reaction [Histamine results in decreased expression of IL12A protein]; HRH2 protein promotes the reaction [Histamine results in decreased expression of IL12B protein]; HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]; tiotidine inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein] [[thioperamide results in increased abundance of Histamine] which results in increased activity of HRH2 protein] which results in decreased susceptibility to Scopolamine; [Famotidine binds to and results in decreased activity of HRH2 protein] which affects the susceptibility to Histamine; [roxatidine acetate binds to and results in decreased activity of HRH2 protein] which affects the susceptibility to Histamine; [thioperamide results in increased abundance of Histamine] which results in increased activity of HRH2 protein; Cimetidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in decreased susceptibility to Scopolamine]; Histamine binds to and results in increased activity of HRH2 protein; Histamine inhibits the reaction [tiotidine binds to HRH2 protein] HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]]; HRH2 protein affects the reaction [Histamine results in increased expression of IL18 protein] Histamine affects the expression of HRH2 protein |
CTD |
PMID:9187264 PMID:9681472 PMID:9819373 PMID:10569698 PMID:11306145 PMID:11640976 PMID:11752121 PMID:12010879 PMID:12235264 PMID:12832840 PMID:14499251 PMID:15843518 PMID:15961859 PMID:16143415 PMID:16723495 PMID:19215234 PMID:19277450 PMID:22926047 More...
|
|
NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
|
|
G |
HRH3 |
histamine receptor H3 |
multiple interactions |
EXP ISO |
Histamine binds to and results in increased activity of HRH3 protein Histamine binds to Hrh3 protein; Histamine inhibits the reaction [N-methylhistamine binds to Hrh3 protein] [Histamine binds to and results in increased activity of HRH3 protein] which results in increased transport of Calcium; Histamine binds to and results in increased activity of HRH3 protein |
CTD RGD |
PMID:12706455 PMID:10869375 |
RGD:632981 |
NCBI chr20:62,214,960...62,220,278
Ensembl chr20:62,214,960...62,220,278
|
|
G |
HRH4 |
histamine receptor H4 |
multiple interactions increases response to substance increases activity |
EXP |
1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine inhibits the reaction [HRH4 protein results in increased susceptibility to Histamine]; [Histamine binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium; [Histamine binds to and results in increased activity of HRH4 protein] which results in increased phosphorylation of MAPK1 protein; [Histamine binds to and results in increased activity of HRH4 protein] which results in increased phosphorylation of MAPK3 protein; [Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12A protein; [Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12B protein; [HRH4 protein results in increased susceptibility to Histamine] which results in decreased expression of CCND1 protein; [HRH4 protein results in increased susceptibility to Histamine] which results in decreased expression of CDK2 protein; [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1A protein; [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein; Histamine binds to and results in increased activity of HRH4 protein; Histamine promotes the reaction [Guanosine 5'-O-(3-Thiotriphosphate) binds to HRH4 protein]; U 0126 inhibits the reaction [[Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12A protein]; U 0126 inhibits the reaction [[Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12B protein] |
CTD |
PMID:11181941 PMID:15843518 PMID:22363581 |
|
NCBI chr18:24,460,637...24,479,974
Ensembl chr18:24,460,637...24,479,961
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]]; Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]] |
CTD |
PMID:11752121 PMID:12364868 PMID:12538815 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNG |
interferon gamma |
multiple interactions affects expression |
EXP ISO |
[Histamine binds to and results in increased activity of HRH2 protein] which results in decreased expression of IFNG mRNA; [Histamine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Cimetidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]; Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]; Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA]]; HRH2 protein promotes the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG mRNA]; Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein]] Histamine affects the expression of IFNG protein |
CTD |
PMID:10569698 PMID:11752121 PMID:12364868 PMID:17346280 PMID:19277450 PMID:29594315 More...
|
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
EXP |
[IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Terfenadine inhibits the reaction [Histamine results in increased expression of IL10 protein] |
CTD |
PMID:11752121 PMID:12925206 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
multiple interactions increases expression decreases expression |
EXP |
[Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12A protein; [Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12A protein; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Cyclic AMP promotes the reaction [[Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12A protein]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; HRH2 protein promotes the reaction [Histamine results in decreased expression of IL12A protein]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Ranitidine inhibits the reaction [Histamine results in decreased expression of IL12A protein]; U 0126 inhibits the reaction [[Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12A protein] Histamine results in increased expression of IL12A protein Histamine results in decreased expression of IL12A mRNA; Histamine results in decreased expression of IL12A protein |
CTD |
PMID:9819373 PMID:11752121 PMID:12364868 PMID:15843518 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
decreases expression increases expression multiple interactions |
EXP |
Histamine results in decreased expression of IL12B mRNA; Histamine results in decreased expression of IL12B protein Histamine results in increased expression of IL12B protein [Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12B protein; [Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12B protein; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Cyclic AMP promotes the reaction [[Histamine results in increased activity of HRH2 protein] which results in decreased expression of IL12B protein]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; HRH2 protein promotes the reaction [Histamine results in decreased expression of IL12B protein]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Ranitidine inhibits the reaction [Histamine results in decreased expression of IL12B protein]; U 0126 inhibits the reaction [[Histamine results in increased activity of HRH4 protein] which results in decreased expression of IL12B protein] |
CTD |
PMID:9819373 PMID:11752121 PMID:12364868 PMID:15843518 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL16 |
interleukin 16 |
multiple interactions increases expression |
EXP |
Cimetidine inhibits the reaction [HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]]; HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]; thioperamide inhibits the reaction [Histamine results in increased expression of IL16 protein] |
CTD |
PMID:12235264 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL18 |
interleukin 18 |
multiple interactions increases expression |
EXP ISO |
[IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; [IL12A protein binds to IL12B protein] inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]; Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]; Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]; Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Histamine results in increased expression of IL18 protein]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]] HRH2 protein affects the reaction [Histamine results in increased expression of IL18 protein] |
CTD |
PMID:11752121 PMID:12364868 PMID:16723495 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
IL1B protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] Histamine results in increased expression of IL1B mRNA |
CTD |
PMID:11164953 PMID:36565801 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
ISO EXP |
Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] [Histamine co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:19277450 PMID:29594315 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
multiple interactions increases response to substance |
ISO |
Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]] IL4 protein results in increased susceptibility to Histamine |
CTD |
PMID:12370375 PMID:19277450 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
multiple interactions |
EXP |
Terfenadine inhibits the reaction [Histamine results in increased expression of IL5 protein] |
CTD |
PMID:12925206 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases secretion increases expression |
EXP ISO |
Calcimycin inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]; Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]; Diphenhydramine inhibits the reaction [Histamine results in increased expression of IL6 protein]; Edetic Acid inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]; fexofenadine inhibits the reaction [Histamine results in increased expression of IL6 protein]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased expression of IL6 mRNA]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased secretion of IL6 protein]; HRH1 protein promotes the reaction [Histamine results in increased expression of IL6 protein]; Lipopolysaccharides promotes the reaction [Histamine results in increased expression of IL6 protein]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased expression of IL6 mRNA]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased secretion of IL6 protein]; TNF protein promotes the reaction [Histamine results in increased expression of IL6 protein] Histamine results in increased expression of IL6 mRNA; Histamine results in increased expression of IL6 protein |
CTD |
PMID:9657254 PMID:9856766 PMID:11238657 PMID:11336536 PMID:29452068 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
ITGA2 |
integrin subunit alpha 2 |
multiple interactions |
ISO |
ITGA2 protein results in increased susceptibility to [KNG1 protein modified form co-treated with TAC1 protein modified form co-treated with Serotonin co-treated with Dinoprostone co-treated with Histamine] |
CTD |
PMID:18234883 |
|
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
|
|
G |
KCNQ2 |
potassium voltage-gated channel subfamily Q member 2 |
multiple interactions |
EXP |
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]; Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein] |
CTD |
PMID:12147327 |
|
NCBI chr20:63,400,208...63,472,655
Ensembl chr20:63,400,208...63,472,677
|
|
G |
KCNQ3 |
potassium voltage-gated channel subfamily Q member 3 |
multiple interactions |
EXP |
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]; Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein] |
CTD |
PMID:12147327 |
|
NCBI chr 8:132,120,861...132,481,095
Ensembl chr 8:132,120,861...132,481,095
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions |
ISO |
[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased abundance of Dinoprostone; [KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein; [Serotonin co-treated with Histamine] promotes the reaction [KNG1 protein results in increased abundance of Dinoprostone]; Dinoprostone promotes the reaction [Histamine promotes the reaction [Serotonin promotes the reaction [KNG1 protein results in increased secretion of TAC1 protein]]]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased abundance of Dinoprostone]; Flurbiprofen inhibits the reaction [[KNG1 protein co-treated with Serotonin co-treated with Histamine] results in increased secretion of CALCA protein]; Flurbiprofen inhibits the reaction [[Serotonin co-treated with Histamine] promotes the reaction [KNG1 protein results in increased abundance of Dinoprostone]]; Flurbiprofen inhibits the reaction [Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]]; Histamine promotes the reaction [[KNG1 protein co-treated with Serotonin] results in increased secretion of CALCA protein]; Histamine promotes the reaction [Serotonin promotes the reaction [KNG1 protein results in increased secretion of TAC1 protein]]; ITGA2 protein results in increased susceptibility to [KNG1 protein modified form co-treated with TAC1 protein modified form co-treated with Serotonin co-treated with Dinoprostone co-treated with Histamine] |
CTD |
PMID:11166334 PMID:12791437 PMID:18234883 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
LTC4S |
leukotriene C4 synthase |
decreases response to substance |
EXP |
LTC4S polymorphism results in decreased susceptibility to Histamine |
CTD |
PMID:19862937 |
|
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
[Histamine binds to and results in increased activity of HRH4 protein] which results in increased phosphorylation of MAPK1 protein; Famotidine inhibits the reaction [Histamine results in increased phosphorylation of MAPK1 protein]; Histamine results in increased phosphorylation of and results in increased activity of MAPK1 protein; Hydrogen Peroxide promotes the reaction [Histamine results in increased phosphorylation of MAPK1 protein]; Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; RTKI cpd inhibits the reaction [Histamine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11181941 PMID:16009787 PMID:17656145 PMID:21179406 PMID:30310171 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
[Histamine binds to and results in increased activity of HRH4 protein] which results in increased phosphorylation of MAPK3 protein; Famotidine inhibits the reaction [Histamine results in increased phosphorylation of MAPK3 protein]; Histamine results in increased phosphorylation of and results in increased activity of MAPK3 protein; Hydrogen Peroxide promotes the reaction [Histamine results in increased phosphorylation of MAPK3 protein]; Pyrilamine inhibits the reaction [Histamine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; RTKI cpd inhibits the reaction [Histamine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11181941 PMID:16009787 PMID:17656145 PMID:21179406 PMID:30310171 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Histamine inhibits the reaction [decamethrin results in decreased nitrosation of MAPK8 protein] |
CTD |
PMID:25299849 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MMP1 |
matrix metallopeptidase 1 |
multiple interactions increases expression increases secretion |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased expression of MMP1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased secretion of MMP1 protein]; EGFR protein affects the reaction [Histamine results in increased secretion of MMP1 protein]; Famotidine inhibits the reaction [Histamine results in increased expression of MMP1 mRNA]; Famotidine inhibits the reaction [Histamine results in increased secretion of MMP1 protein]; RTKI cpd inhibits the reaction [Histamine results in increased expression of MMP1 mRNA]; RTKI cpd inhibits the reaction [Histamine results in increased secretion of MMP1 protein] |
CTD |
PMID:9856766 PMID:17656145 |
|
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions increases secretion increases expression |
EXP |
Chlorpheniramine inhibits the reaction [Histamine results in increased expression of MUC5AC mRNA]; Chlorpheniramine inhibits the reaction [Histamine results in increased expression of MUC5AC protein]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased expression of MUC5AC mRNA]; Glycyrrhizic Acid inhibits the reaction [Histamine results in increased secretion of MUC5AC protein]; Niflumic Acid inhibits the reaction [Histamine results in increased expression of MUC5AC mRNA]; Niflumic Acid inhibits the reaction [Histamine results in increased expression of MUC5AC protein]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased expression of MUC5AC mRNA]; prolinedithiocarbamate inhibits the reaction [Histamine results in increased secretion of MUC5AC protein] Histamine results in increased expression of MUC5AC mRNA; Histamine results in increased expression of MUC5AC protein |
CTD |
PMID:17622767 PMID:29452068 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions affects localization |
EXP |
Histamine promotes the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Histamine promotes the reaction [TNF protein affects the localization of NFKB1 protein] Histamine affects the localization of NFKB1 protein |
CTD |
PMID:11336536 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases phosphorylation multiple interactions |
EXP |
Histamine results in increased phosphorylation of NFKBIA protein Glycyrrhizic Acid inhibits the reaction [Histamine results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:29452068 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein; Pyrilamine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein]; Triprolidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of NGF protein] |
CTD |
PMID:15167971 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression increases phosphorylation |
EXP ISO |
[PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein]; Deoxyglucose promotes the reaction [STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein]]; STK11 protein promotes the reaction [Histamine results in increased phosphorylation of NOS2 protein]; STO 609 inhibits the reaction [Histamine results in increased phosphorylation of NOS2 protein] Histamine results in increased expression of NOS2 protein |
CTD |
PMID:21145922 PMID:36565801 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
Histamine inhibits the reaction [decamethrin results in decreased expression of NOS3 protein] |
CTD |
PMID:25299849 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NTF3 |
neurotrophin 3 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Histamine results in increased expression of NTF3 protein]; [Pyrilamine co-treated with Famotidine co-treated with ciproxifan] inhibits the reaction [Histamine results in increased expression of NTF3 protein]; [Pyrilamine co-treated with Famotidine] inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Cimetidine inhibits the reaction [Histamine results in increased expression of NTF3 protein]; ciproxifan inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Famotidine inhibits the reaction [Histamine results in increased expression of NTF3 protein]; KN 62 inhibits the reaction [Histamine results in increased expression of NTF3 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Pertussis Toxin inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Pyrilamine inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Staurosporine inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Histamine results in increased expression of NTF3 protein]; thioperamide inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Triprolidine inhibits the reaction [Histamine results in increased expression of NTF3 protein] Histamine results in increased expression of NTF3 mRNA; Histamine results in increased expression of NTF3 protein |
CTD |
PMID:21276809 |
|
NCBI chr12:5,430,332...5,495,299
Ensembl chr12:5,432,108...5,521,536
|
|
G |
PCNA |
proliferating cell nuclear antigen |
affects expression |
ISO |
Histamine affects the expression of PCNA protein |
CTD |
PMID:17729160 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDE4B |
phosphodiesterase 4B |
multiple interactions increases expression |
EXP |
Cimetidine inhibits the reaction [Histamine results in increased expression of PDE4B mRNA] |
CTD |
PMID:11131300 |
|
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
|
|
G |
PLA2G4A |
phospholipase A2 group IVA |
multiple interactions increases expression |
EXP |
Dexamethasone inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA]; Diphenhydramine inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA]; MK-886 inhibits the reaction [Histamine results in increased expression of PLA2G4A mRNA] |
CTD |
PMID:9609743 |
|
NCBI chr 1:186,828,949...186,988,981
Ensembl chr 1:186,828,949...186,988,981
|
|
G |
PPP3CA |
protein phosphatase 3 catalytic subunit alpha |
increases expression |
ISO |
Histamine results in increased expression of PPP3CA protein |
CTD |
PMID:30310171 |
|
NCBI chr 4:101,023,418...101,347,526
Ensembl chr 4:101,023,409...101,348,278
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
EXP |
[PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] |
CTD |
PMID:21145922 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
[PRKAA1 protein co-treated with PRKAA2 protein] affects the reaction [Histamine results in increased phosphorylation of NOS2 protein] |
CTD |
PMID:21145922 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRKCD |
protein kinase C delta |
multiple interactions |
EXP |
epigallocatechin gallate inhibits the reaction [Histamine results in increased phosphorylation of PRKCD protein]; Histamine results in increased phosphorylation of and affects the localization of PRKCD protein; Quercetin inhibits the reaction [Histamine results in increased phosphorylation of and affects the localization of PRKCD protein] |
CTD |
PMID:23333628 |
|
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
[SC 560 binds to and results in decreased activity of PTGS1 protein] promotes the reaction [Histamine results in increased secretion of Acids] |
CTD |
PMID:16299412 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
Histamine promotes the reaction [[TLR2 results in increased expression of PTGS2] which results in increased chemical synthesis of Dinoprostone]; Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]; HRH1 affects the reaction [Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]] Histamine results in increased expression of PTGS2 mRNA |
CTD |
PMID:20040740 PMID:36565801 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPRC |
protein tyrosine phosphatase receptor type C |
multiple interactions |
EXP |
[alpha-fluoromethylhistamine results in decreased chemical synthesis of Histamine] which results in decreased expression of PTPRC protein; [tiotidine inhibits the reaction [Histamine binds to and results in increased activity of HRH2 protein]] which results in decreased expression of PTPRC protein; [Triprolidine inhibits the reaction [Histamine binds to and results in increased activity of HRH1 protein]] which results in decreased expression of PTPRC protein |
CTD |
PMID:11306145 |
|
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,757,476
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
affects localization increases phosphorylation multiple interactions |
EXP |
Histamine affects the localization of RELA protein Histamine results in increased phosphorylation of RELA protein Glycyrrhizic Acid inhibits the reaction [Histamine results in increased phosphorylation of RELA protein]; Histamine promotes the reaction [Lipopolysaccharides affects the localization of RELA protein]; Histamine promotes the reaction [TNF protein affects the localization of RELA protein]; Histamine results in increased activity of [CXCL8 protein binds to RELA protein] |
CTD |
PMID:9609743 PMID:11336536 PMID:29452068 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SLC18A1 |
solute carrier family 18 member A1 |
multiple interactions |
EXP |
Histamine inhibits the reaction [SLC18A1 protein results in increased uptake of Serotonin] |
CTD |
PMID:8245983 |
|
NCBI chr 8:20,144,855...20,183,136
Ensembl chr 8:20,144,855...20,183,206
|
|
G |
SLC18A2 |
solute carrier family 18 member A2 |
multiple interactions affects binding increases secretion |
ISO EXP |
Rabeprazole promotes the reaction [SLC18A2 protein results in increased secretion of Histamine] Histamine binds to SLC18A2 protein |
CTD |
PMID:7912402 PMID:14642791 |
|
NCBI chr10:117,241,114...117,279,430
Ensembl chr10:117,241,093...117,279,430
|
|
G |
SLC22A3 |
solute carrier family 22 member 3 |
multiple interactions increases uptake increases transport affects uptake |
ISO EXP |
Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Estradiol inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Histamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; pseudoisocyanine inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Serotonin inhibits the reaction [SLC22A3 protein results in increased transport of Histamine] SLC22A3 protein results in increased uptake of Histamine SLC22A3 protein polymorphism affects the uptake of Histamine |
CTD |
PMID:12411423 PMID:16928864 PMID:20562519 PMID:20858707 |
|
NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
|
|
G |
SLC29A4 |
solute carrier family 29 member 4 |
increases uptake |
EXP |
SLC29A4 protein results in increased uptake of Histamine |
CTD |
PMID:20858707 |
|
NCBI chr 7:5,282,943...5,306,912
Ensembl chr 7:5,274,369...5,306,912
|
|
G |
SLC47A1 |
solute carrier family 47 member 1 |
multiple interactions |
EXP |
Histamine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
|
|
G |
SLC47A2 |
solute carrier family 47 member 2 |
multiple interactions |
EXP |
Histamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr17:19,678,317...19,718,979
Ensembl chr17:19,678,288...19,718,979
|
|
G |
SOD1 |
superoxide dismutase 1 |
affects expression |
ISO |
Histamine affects the expression of SOD1 protein |
CTD |
PMID:17729160 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SST |
somatostatin |
multiple interactions |
ISO |
SST protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; SST protein inhibits the reaction [GAST protein results in increased secretion of Histamine] |
CTD |
PMID:11164953 |
|
NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
|
|
G |
STAT6 |
signal transducer and activator of transcription 6 |
increases expression |
EXP |
Histamine results in increased expression of STAT6 protein |
CTD |
PMID:12755381 |
|
NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
|
|
G |
STK11 |
serine/threonine kinase 11 |
multiple interactions increases phosphorylation |
EXP |
STK11 protein promotes the reaction [Histamine results in increased abundance of Cyclic GMP]; STK11 protein promotes the reaction [Histamine results in increased phosphorylation of NOS2 protein] Histamine results in increased phosphorylation of STK11 protein |
CTD |
PMID:21145922 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
|
|
G |
TAAR1 |
trace amine associated receptor 1 |
increases activity multiple interactions |
ISO |
Histamine results in increased activity of TAAR1 protein [Histamine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP |
CTD |
PMID:19725810 |
|
NCBI chr 6:132,643,312...132,659,182
Ensembl chr 6:132,643,312...132,659,182
|
|
G |
TAC1 |
tachykinin precursor 1 |
multiple interactions increases secretion |
EXP ISO |
Nedocromil inhibits the reaction [TAC1 protein results in increased secretion of Histamine]; Theophylline inhibits the reaction [TAC1 protein results in increased secretion of Histamine] Dinoprostone promotes the reaction [Histamine promotes the reaction [Serotonin promotes the reaction [KNG1 protein results in increased secretion of TAC1 protein]]]; Histamine promotes the reaction [Serotonin promotes the reaction [KNG1 protein results in increased secretion of TAC1 protein]]; ITGA2 protein results in increased susceptibility to [KNG1 protein modified form co-treated with TAC1 protein modified form co-treated with Serotonin co-treated with Dinoprostone co-treated with Histamine] |
CTD |
PMID:1707400 PMID:9291295 PMID:11166334 PMID:18234883 |
|
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
|
|
G |
TLR2 |
toll like receptor 2 |
multiple interactions |
EXP |
Histamine promotes the reaction [[TLR2 results in increased expression of PTGS2] which results in increased chemical synthesis of Dinoprostone]; Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]; HRH1 affects the reaction [Histamine promotes the reaction [TLR2 results in increased expression of PTGS2]] |
CTD |
PMID:20040740 |
|
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
Famotidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; Famotidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]; Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Histamine promotes the reaction [TNF protein affects the localization of NFKB1 protein]; Histamine promotes the reaction [TNF protein affects the localization of RELA protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]]; Ranitidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; TNF protein promotes the reaction [Histamine results in increased expression of CCL2 protein]; TNF protein promotes the reaction [Histamine results in increased expression of CXCL8 protein]; TNF protein promotes the reaction [Histamine results in increased expression of IL6 protein] Histamine results in increased expression of TNF mRNA; Histamine results in increased expression of TNF protein TNF protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; TNF protein inhibits the reaction [GAST protein results in increased secretion of Histamine] Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]; HRH2 protein affects the reaction [Histamine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]] |
CTD |
PMID:11164953 PMID:11336536 PMID:11752121 PMID:12538815 PMID:14499251 PMID:19277450 PMID:36565801 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
UCP2 |
uncoupling protein 2 |
decreases secretion affects secretion affects abundance |
EXP ISO |
UCP2 protein results in decreased secretion of Histamine UCP2 protein affects the secretion of Histamine UCP2 protein affects the abundance of Histamine |
CTD |
PMID:19846869 |
|
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
|
|
G |
VIP |
vasoactive intestinal peptide |
increases secretion |
ISO |
VIP protein results in increased secretion of Histamine |
CTD |
PMID:11164953 |
|
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
|
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
4-methylhistamine results in decreased expression of CCL2 protein |
CTD |
PMID:17507084 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CD14 |
CD14 molecule |
multiple interactions |
EXP |
[4-methylhistamine binds to and results in increased activity of HRH2 protein] which affects the expression of CD14 protein |
CTD |
PMID:14499251 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD80 |
CD80 molecule |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein] |
CTD |
PMID:12538815 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
HRH2 |
histamine receptor H2 |
multiple interactions |
EXP |
4-methylhistamine binds to and results in increased activity of HRH2 protein; [4-methylhistamine binds to and results in increased activity of HRH2 protein] which affects the expression of CD14 protein |
CTD |
PMID:14499251 |
|
NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
|
|
G |
HRH4 |
histamine receptor H4 |
multiple interactions |
EXP |
1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine inhibits the reaction [[4-methylhistamine binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium]; 4-methylhistamine binds to and results in increased activity of HRH4 protein; [4-methylhistamine binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium |
CTD |
PMID:17507084 |
|
NCBI chr18:24,460,637...24,479,974
Ensembl chr18:24,460,637...24,479,961
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; 4-methylhistamine inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] |
CTD |
PMID:11752121 PMID:12364868 PMID:12538815 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNG |
interferon gamma |
affects expression multiple interactions |
EXP |
4-methylhistamine affects the expression of IFNG protein 4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein] |
CTD |
PMID:11752121 PMID:12364868 PMID:17346280 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein] |
CTD |
PMID:11752121 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL12A |
interleukin 12A |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in decreased expression of IL10 protein]; 4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of [IL12A protein binds to IL12B protein]]; 4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of ICAM1 protein]; 4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of IFNG protein]; 4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of TNF protein] |
CTD |
PMID:11752121 PMID:12364868 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
4-methylhistamine inhibits the reaction [IL18 protein results in increased expression of TNF protein]; 4-methylhistamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:11752121 PMID:12538815 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
GAL |
galanin and GMAP prepropeptide |
decreases expression |
ISO |
alpha-methylhistamine results in decreased expression of GAL mRNA |
CTD |
PMID:11956952 |
|
NCBI chr11:68,684,544...68,691,175
Ensembl chr11:68,683,779...68,691,175
|
|
G |
GAST |
gastrin |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [GAST protein modified form results in increased secretion of Histamine] |
CTD |
PMID:2470453 |
|
NCBI chr17:41,712,331...41,715,969
Ensembl chr17:41,712,331...41,715,969
|
|
G |
HDC |
histidine decarboxylase |
decreases expression |
ISO |
alpha-methylhistamine results in decreased expression of HDC mRNA |
CTD |
PMID:11956952 |
|
NCBI chr15:50,241,947...50,265,726
Ensembl chr15:50,241,947...50,265,965
|
|
G |
HRH3 |
histamine receptor H3 |
multiple interactions affects binding |
ISO EXP |
6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one inhibits the reaction [alpha-methylhistamine promotes the reaction [Guanosine Triphosphate binds to HRH3 protein]]; alpha-methylhistamine binds to and results in increased activity of HRH3 protein; alpha-methylhistamine promotes the reaction [Guanosine Triphosphate binds to HRH3 protein] alpha-methylhistamine binds to HRH3 protein 6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one inhibits the reaction [alpha-methylhistamine promotes the reaction [Guanosine Triphosphate binds to HRH3 protein]]; alpha-methylhistamine binds to and results in increased activity of HRH3 protein; alpha-methylhistamine promotes the reaction [Guanosine Triphosphate binds to HRH3 protein]; Endocannabinoids inhibits the reaction [alpha-methylhistamine binds to and results in increased activity of HRH3 protein]; Histamine H3 Antagonists inhibits the reaction [alpha-methylhistamine binds to HRH3 protein] |
CTD |
PMID:11956952 PMID:21634396 PMID:30102254 PMID:31369746 |
|
NCBI chr20:62,214,960...62,220,278
Ensembl chr20:62,214,960...62,220,278
|
|
G |
HRH4 |
histamine receptor H4 |
multiple interactions |
EXP |
[alpha-methylhistamine binds to and results in increased activity of HRH4 protein] which results in increased abundance of Calcium; alpha-methylhistamine binds to and results in increased activity of HRH4 protein; HRH4 protein promotes the reaction [alpha-methylhistamine results in increased expression of IL16 protein] |
CTD |
PMID:11181941 PMID:12235264 |
|
NCBI chr18:24,460,637...24,479,974
Ensembl chr18:24,460,637...24,479,961
|
|
G |
IFNG |
interferon gamma |
affects expression |
EXP |
alpha-methylhistamine affects the expression of IFNG protein |
CTD |
PMID:17346280 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL16 |
interleukin 16 |
multiple interactions increases expression |
EXP |
HRH4 protein promotes the reaction [alpha-methylhistamine results in increased expression of IL16 protein] |
CTD |
PMID:12235264 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of IL1B protein]] |
CTD |
PMID:31369746 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of IL6 protein]] |
CTD |
PMID:31369746 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of NOS2 protein]] |
CTD |
PMID:31369746 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of PTGS2 protein]] |
CTD |
PMID:31369746 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of RELA protein]] |
CTD |
PMID:31369746 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
alpha-methylhistamine inhibits the reaction [Histamine H3 Antagonists inhibits the reaction [Valproic Acid results in increased expression of TNF protein]] |
CTD |
PMID:31369746 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
EXP |
histamine phosphate results in increased expression of F3 protein |
CTD |
PMID:25569083 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
increases metabolic processing |
EXP |
AOC1 protein results in increased metabolism of tele-methylhistamine |
CTD |
PMID:12072962 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
HRH3 |
histamine receptor H3 |
affects binding |
ISO |
N(tele)-methylhistamine binds to Hrh3 protein |
RGD |
PMID:10869375 |
RGD:632981 |
NCBI chr20:62,214,960...62,220,278
Ensembl chr20:62,214,960...62,220,278
|
|